Description
This intensive 90-minute course focuses on these key industry drivers: change in the global market mix,
product pipelines, generics, product life cycle, development & manufacturing efficiency, emerging biologics,
and profits. Following benchmark review, the course provides footprints for turnaround strategies.<br><br>
<b>Module 1:</b><br>
<li>The evolving global drug business</li>
<li>Industry benchmarks</li>
<li>How did we get here?</li>
<li>Where we are going</li><br><br>
<b>Module 2:</b><br>
<li>Pipeline and product issues</li>
<li>Lifting the regulatory veil</li>
<li>The new ethical, biologic and generic drug mix</li>
<li>Critical path and Quality Risk Management</li><br><br>
<b>Module 3:</b><br>
<li>Risk & reward from development through manufacturing</li>
<li>Niche focus for drug products</li>
<li>Outsourcing and plant capacity</li>
<li>Turnaround strategies</li>
AN ONLINE TRAINING FORMAT
AN ONLINE TRAINING FORMAT,